Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc. V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is committed to becoming a health innovator and applying technologies at the forefront of science to core health issues at the community pharmacy level. The Company’s goal is to empower consumers, patients and pharmacists with innovative technology, products, services and information to monitor and optimize health.


TSXV:AVCR - Post by User

Bullboard Posts
Comment by kingposton Jan 04, 2015 11:45pm
138 Views
Post# 23284965

RE:RE:Iscfa which is it to be

RE:RE:Iscfa which is it to be
lscfa wrote: Teva and Mylan do have 50% gross profit margins. They manufacture the generics. That is the gross up you can expect Vanc's manufacturers to charge it. Net profit margins on the drugs Vanc resells to pharmacies is another story. If my 10% estimate is so off base please enlighten us with some solid evidence to the contrary.



We should have higher margins than teva and mylan ... since:
-generic drugs sell for more in Canada
-we can order production batches and do not have all the overhead of setting up and long term maintenance of  the fda approved plants over seas.. 
Bullboard Posts